MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by MoonLake Immunotherapeutics insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 6 filings
- 2 insiders, $5.28M in total
- Insiders trading
- 2
- Net value
- −$5.28M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for MoonLake Immunotherapeutics, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Reich Kristian | Chief Scientific Officer | 2,711,198Indirect | Jul 29, 2026 | 8 |
| Santos da Silva Jorge | Chief Executive Officer | 2,774,893 | Jul 13, 2026 | 6 |
| Bodenstedt Matthias | Chief Financial Officer | 1,115,435 | Jun 23, 2026 | 8 |
| Biotechnology Value Fund L P | Director, 10% Owner | 1,039,238 | Jun 22, 2026 | 2 |
| BVF Partners L P | Director, 10% Owner | 1,039,238 | Jun 22, 2026 | 2 |
| BVF Inc | Director, 10% Owner | 1,039,238 | Jun 22, 2026 | 2 |
| Biotechnology Value Fund II LP | Director, Other: See Explanation of Responses | 1,039,238 | Jun 22, 2026 | 2 |
| Lampert Mark N | Director, 10% Owner | 1,039,238 | Jun 22, 2026 | 2 |
| Biotechnology Value Trading Fund OS LP | Director, Other: See Explanation of Responses | 1,039,238 | Jun 22, 2026 | 2 |
| BVF Partners OS Ltd. | Director, Other: See Explanation of Responses | 1,039,238 | Jun 22, 2026 | 2 |
| BVF I GP LLC | Director, 10% Owner | 1,039,238 | Jun 22, 2026 | 2 |
| BVF II GP LLC | Director, Other: See Explanation of Responses | 1,039,238 | Jun 22, 2026 | 2 |
| BVF GP Holdings LLC | Director, 10% Owner | 1,039,238 | Jun 22, 2026 | 2 |
| Moukheibir Catherine | Director | 0 | Jun 18, 2026 | 1 |
| Loy Spike | Director | – | Jun 18, 2026 | 1 |
| Xavier Ramnik | Director | – | Jun 18, 2026 | 1 |
| Phillips Andrew John | Director | – | Jun 18, 2026 | 1 |
| Cormorant Asset Management, LP | Other: Former 10% Owner | 1,994,173Indirect | Oct 1, 2025 | 1 |
| Chen Bihua | Other: Former 10% Owner | 1,994,173Indirect | Oct 1, 2025 | 1 |
| Cormorant Global Healthcare Master Fund, LP | Other: Former 10% Owner | 1,994,173Indirect | Oct 1, 2025 | 1 |
| Cormorant Private Healthcare Fund II, LP | Other: Former 10% Owner | 1,994,173Indirect | Oct 1, 2025 | 1 |
| Cormorant Private Healthcare Fund III LP | Other: Former 10% Owner | 1,994,173Indirect | Oct 1, 2025 | 1 |
| Cormorant Private Healthcare Fund IV LP | Other: Former 10% Owner | 1,994,173Indirect | Oct 1, 2025 | 1 |
| Sturge Simon | Director | 171,980 | Jun 9, 2025 | 0 |
| Helix Holdings LLC | Other: Former 10% Holder | 3,215,000 | Apr 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 (view filing)4:10 PM ET | Jul 27 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −1.10K | $20.00 | −$22.0K | 0.0%2.71M after | 10b5-1 |
| Jul 23, 2026 (view filing)4:05 PM ET | Jul 21-22 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −52.4K | $20.02 | −$1.05M | −1.9%2.71M after | 2 lots10b5-1 |
| Jul 21, 2026 (view filing)6:13 PM ET | Jul 20 | 1 day | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −43.7K | $20.09 | −$877.9K | −1.6%2.76M after | 10b5-1 |
| Jul 20, 2026 (view filing)6:07 AM ET | Jul 15 | 5 daysLate | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −16.1K | $20.01 | −$322.3K | −0.6%2.81M after | 10b5-1 |
| Jul 13, 2026 (view filing)4:10 PM ET | Jul 9-10 | 4 days | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −102.2K | $20.02 | −$2.05M | −3.6%2.77M after | 2 lots10b5-1 |
| Jul 2, 2026 (view filing)4:10 PM ET | Jul 1 | 1 day | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −47.8K | $20.03 | −$956.9K | −1.6%2.88M after | 10b5-1 |
| Jun 23, 2026 (view filing) | Jun 22 | 1 day | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −39.1K | $22.04 | −$862.2K | −3.4%1.12M after | 10b5-1 |
| Jun 18, 2026 (view filing) | Jun 17-18 | 1 day | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −17.9K | $19.67 | −$351.6K | −1.5%1.15M after | 2 lots10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15-17 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −150.0K | $19.01 | −$2.85M | −5.0%2.82M after | 3 lots10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −13.7K | $20.02 | −$273.3K | −1.2%1.17M after | 10b5-1 |
| Apr 16, 2026 (view filing) | Apr 14 | 2 days | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −2.43K | $19.56 | −$47.5K | −0.2%1.19M after | 10b5-1 |
| Apr 14, 2026 (view filing) | Apr 10-13 | 4 days | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −150.0K | $18.35 | −$2.75M | −4.9%2.92M after | 2 lots |
| Apr 10, 2026 (view filing) | Apr 9-10 | 1 day | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −87.8K | $18.95 | −$1.66M | −6.9%1.19M after | 2 lots10b5-1 |
| Apr 2, 2026 (view filing)4:48 PM ET | Mar 31 | 2 days | Biotechnology Value Fund L P and 9 othersDirector, 10% Owner | SSaleClass A Ordinary Shares, $0.0001 par value | −3.75M | $16.79 | −$63.0M | −78.3%1.04M after | 3 lots |
| Dec 10, 2025 (view filing) | Dec 8-9 | 2 days | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −200.0K | $14.87 | −$2.97M | −6.5%2.88M after | 2 lots |
| Dec 10, 2025 (view filing) | Dec 8-9 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −202.9K | $14.85 | −$3.01M | −100.0%0 after | 2 lots |
| Oct 9, 2025 (view filing) | Oct 8 | 1 day | Bodenstedt MatthiasChief Financial Officer | PPurchaseClass A ordinary shares, par value $0.0001 per share | +10.9K | $9.09 | +$98.8K | +1.8%627.5K after | |
| Oct 1, 2025 (view filing)5:22 PM ET | Sep 29-30 | 2 days | Cormorant Asset Management, LP and 5 othersOther: Former 10% Owner | SSaleClass A Ordinary Shares | −6.50M | $7.21 | −$46.9M | −76.5%1.99M after | 5 lots |
| Jul 7, 2025 (view filing) | Jul 3 | 4 days | Moukheibir CatherineDirector | SSaleClass A ordinary shares, par value $0.0001 per share | −23.5K | $48.79 | −$1.15M | −100.0%0 after | |
| Oct 8, 2024 (view filing)6:50 PM ET | Oct 4 | 4 days | Biotechnology Value Fund L P and 9 othersDirector, 10% Owner | SSaleClass A Ordinary Shares, $0.0001 par value | −2.00M | $50.00 | −$100.0M | −60.8%1.29M after | 3 lots |
| Oct 8, 2024 (view filing) | Oct 4 | 4 days | Sturge SimonDirector | SSaleClass A ordinary shares, par value $0.0001 per share | −171.0K | $53.72 | −$9.19M | −49.9%172.0K after | |
| Feb 29, 2024 (view filing) | Feb 27-29 | 2 days | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −123.6K | $55.03 | −$6.80M | −4.0%2.98M after | 3 lots10b5-1 |
| Feb 29, 2024 (view filing) | Feb 27-28 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −61.4K | $55.00 | −$3.38M | −2.1%2.93M after | 2 lots10b5-1 |
| Feb 29, 2024 (view filing) | Feb 27-28 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −57.5K | $55.00 | −$3.16M | −57.8%42.0K after | 2 lots10b5-1 |
| Feb 23, 2024 (view filing) | Feb 21 | 2 days | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −1.13K | $55.27 | −$62.2K | 0.0%3.11M after | 10b5-1 |
| Feb 22, 2024 (view filing) | Feb 20-21 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −10.5K | $57.35 | −$602.7K | −0.4%2.99M after | 2 lots10b5-1 |
| Feb 22, 2024 (view filing) | Feb 20-21 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −10.6K | $57.32 | −$605.8K | −9.6%99.5K after | 2 lots10b5-1 |
| Feb 20, 2024 (view filing) | Feb 15-20 | 5 days | Santos da Silva JorgeChief Executive Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −60.0K | $59.26 | −$3.56M | −1.9%3.11M after | 3 lots10b5-1 |
| Feb 16, 2024 (view filing) | Feb 14-16 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −30.0K | $60.91 | −$1.83M | −1.0%3.00M after | 3 lots10b5-1 |
| Feb 16, 2024 (view filing) | Feb 14-16 | 2 days | Reich KristianChief Scientific Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −30.0K | $60.91 | −$1.83M | −21.4%110.1K after | 3 lots10b5-1 |
| Dec 21, 2023 (view filing) | Dec 19-20 | 2 days | Bodenstedt MatthiasChief Financial Officer | SSaleClass A ordinary shares, par value $0.0001 per share | −100.0K | $59.17 | −$5.92M | −16.1%520.9K after | 2 lots10b5-1 |
| Oct 10, 2023 (view filing)4:00 PM ET | Oct 5 | 5 days | Cormorant Asset Management, LP and 5 others10% Owner | PPurchaseClass A Ordinary Shares | +58.8K | $59.90 | +$3.52M | +0.7%8.49M after | |
| Oct 4, 2023 (view filing)5:52 PM ET | Oct 2-4 | 2 days | Cormorant Asset Management, LP and 5 others10% Owner | PPurchaseClass A Ordinary Shares | +293.2K | $57.30 | +$16.8M | +3.6%8.44M after | 3 lots |
| Jul 5, 2023 (view filing) | Jun 30 | 5 days | Chen Bihua10% Owner | PPurchaseClass A Ordinary Shares | +800.0K | $50.00 | +$40.0M | +19.4%4.93M after | |
| Jun 28, 2023 (view filing) | Jun 26 | 2 days | Chen Bihua10% Owner | PPurchaseClass A Ordinary Shares | +450.0K | $45.63 | +$20.5M | +12.2%4.13M after | 27 lots |
| Mar 22, 2023 (view filing) | Mar 20-21 | 2 days | Chen Bihua10% Owner | PPurchaseClass A Ordinary Shares | +827.1K | $20.28 | +$16.8M | +29.0%3.68M after | 4 lots |
| Apr 7, 2022 (view filing) | Apr 5 | 2 days | Chen Bihua10% Owner | PPurchaseClass A Ordinary Shares | +2.85M | $10.00 | +$28.5M | New position2.85M after |